share_log

Benchmark Reiterates Buy on Nutex Health, Maintains $2.5 Price Target

Benzinga ·  Aug 29, 2023 08:17

Benchmark analyst Bill Sutherland reiterates Nutex Health (NASDAQ:NUTX) with a Buy and maintains $2.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment